Daclizumab Subcutaneous and DDAVP
Determining the interaction of Daclizumab Subcutaneous and DDAVP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: desmopressin
Brand name: DDAVP, Nocdurna, DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate
Synonyms: DDAVP (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-DDAVP (Desmopressin Injection Solution)
- Daclizumab Subcutaneous-DDAVP (Desmopressin Nasal Spray (Diabetes Insipidus))
- Daclizumab Subcutaneous-DDAVP (Desmopressin Tablets)
- Daclizumab Subcutaneous-DDAVP injection
- Daclizumab Subcutaneous-DDAVP nasal
- Daclizumab Subcutaneous-DDAVP Nasal Spray
- DDAVP-Dacogen
- DDAVP-Dacomitinib
- DDAVP-Dactinomycin
- DDAVP-Dactinomycin Injection
- DDAVP-Dactinomycin Intravenous
- DDAVP-Daklinza